NCT05940493View on ClinicalTrials.gov

Abemaciclib in Newly Diagnosed Meningioma Patients

PHASE2RecruitingINTERVENTIONAL

Enrollment

72

Participants

Timeline

Start Date

March 24, 2025

Primary Completion Date

September 30, 2028

Study Completion Date

September 30, 2030

Conditions

Meningioma

Interventions

DRUG

Abemaciclib

Tablet

DRUG

Placebo

Tablet

Trial Locations (1)

85013

RECRUITING

St. Joseph's Hospital and Medical Center, Phoenix

All Listed Sponsors

collaborator

Eli Lilly and Company

INDUSTRY

collaborator

Barrow Neurological Institute

OTHER

collaborator

Ivy Brain Tumor Center

OTHER

lead

Nader Sanai

OTHER